QuidelOrtho (QDEL) Capital Expenditures (2021 - 2026)

QuidelOrtho (QDEL) has 6 years of Capital Expenditures data on file, last reported at $34.0 million in Q1 2026.

• For the quarter ending Q1 2026, Capital Expenditures fell 39.5% year-over-year to $34.0 million; the trailing twelve-month figure through Mar 2026 stood at $166.0 million (down 10.37% YoY), and the FY2025 full-year result was $188.2 million, down 3.54% from the prior year.
• Capital Expenditures eased to $34.0 million in Q1 2026, from $45.3 million in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $66.1 million in Q1 2024 to a low of -$119.5 million in Q1 2023.
• A 5-year average of $35.3 million and a median of $46.5 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures jumped 193.33% in 2023 and slumped 39.5% in 2026, its largest moves.
• Tracing QDEL's Capital Expenditures over 5 years: stood at $22.5 million in 2022, then soared by 116.0% to $48.6 million in 2023, then declined by 2.88% to $47.2 million in 2024, then declined by 4.03% to $45.3 million in 2025, then fell by 24.94% to $34.0 million in 2026.
• Business Quant data shows QDEL's Capital Expenditures at $34.0 million in Q1 2026, $45.3 million in Q4 2025, and $49.2 million in Q3 2025.